The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Effect of Nebulized Ipratropium on the Hospitalization Rates of Children with Asthma
Open accessAbstract
BACKGROUND: Anticholinergic medications such as ipratropium improve the pulmonary function of patients with acute exacerbations of asthma, but their effect on hospitalization rates is uncertain. METHODS: We conducted a randomized, double-blind, placebo-controlled study of 434 children (2 to 18 years old) who had acute exacerbations of moderate or severe asthma treated in the emergency department. All the children received a nebulized solution of albuterol (2.5 or 5 mg per dose, depending on body weight) every 20 minutes for three doses and then as needed. A corticosteroid (2 mg of prednisone or prednisolone per kilogram of body weight) was given orally with the second dose of albuterol. Children in the treatment group received 500 microg (2.5 ml) of ipratropium bromide with the second and third doses of albuterol; children in the control group received 2.5 ml of normal saline at these times. RESULTS: Overall, the rate of hospitalization was lower in the ipratropium group (59 of 215 children [27.4 percent]) than in the control group (80 of 219 [36.5 percent], P=0.05). For patients with moderate asthma (indicated by a peak expiratory flow rate of 50 to 70 percent of the predicted value or an asthma score of 8 to 11 on a 15-point scale), hospitalization rates were similar in the two groups (ipratropium: 8 of 79 children [10.1 percent]; control: 9 of 84 [10.7 percent]). For patients with severe asthma (defined as a peak expiratory flow rate of <50 percent of the predicted value or an asthma score of 12 to 15), the addition of ipratropium significantly reduced the need for hospitalization (51 of 136 children [37.5 percent], as compared with 71 of 135 [52.6 percent] in the control group; P=0.02). CONCLUSIONS: Among children with a severe exacerbation of asthma, the addition of ipratropium bromide to albuterol and corticosteroid therapy significantly decreases the hospitalization rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the diagnosis and management of asthma.
Solomon, P. A. (1992) · PubMed · Cited by 2,004
Evidence-based Medicine: How to Practice and Teach EBM
Satya-Murti, S. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020100049 · Cited by 975
Basic & Clinical Biostatistics
Dawson, B. K., & Trapp, R. G. (2004) · Cited by 699
Rebuck, A. S., Chapman, K. R., Abboud, R., Pare, P. D., Kreisman, H., Wolkove, N., & Vickerson, F. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90378-0 · Cited by 266
Hsu, K. H. K., Jenkins, D. E., Hsi, B. P., Bourhofer, E., Thompson, V., Tanakawa, N., & Hsieh, G. S. J. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80075-x · Cited by 197
Schuh, S., Johnson, D. W., Callahan, S., Canny, G., & Levison, H. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70368-3 · Cited by 194
Efficacy of Nebulized Ipratropium in Severely Asthmatic Children
Qureshi, F. A., ZARITSKY, A. L., & Lakkis, H. D. (1997) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(97)70269-5 · Cited by 85
Self-citationEfficacy of Ipratropium Bromide in Acute Childhood Asthma: A Meta‐analysis
Osmond, M. H., & Klassen, T. P. (1995) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.1995.tb03607.x · Cited by 44
Cited by
Omalizumab for asthma in adults and children
Normansell, R., Walker, S., Milan, S. J., Walters, E. H., & Nair, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003559.pub4 · Cited by 651
Asthma Exacerbations: Pathogenesis, Prevention, and Treatment
Castillo, J. R., Peters, S. P., & Busse, W. W. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.05.001 · Cited by 544
Human pharmaceuticals in US surface waters: A human health risk assessment
Schwab, B. W., Hayes, E. P., Fiori, J. M., Mastrocco, F. J., Roden, N. M., Cragin, D., Meyerhoff, R. D., D’Aco, V. J., & Anderson, P. D. (2005) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2005.05.005 · Cited by 415
Association between human rhinovirus C and severity of acute asthma in children
Bizzintino, J., Lee, W.-M., Laing, I. A., Vang, F., Pappas, T., Zhang, G., Martin, A. C., Khoo, S.-K., Cox, D. W., Geelhoed, G. C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00092410 · Cited by 381
Grassi, D., Howard, S., Zhou, M., Diaz-Perez, N., Urban, N. T., Guerrero-Given, D., Kamasawa, N., Volpicelli-Daley, L. A., LoGrasso, P., & Lasmézas, C. I. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713849115 · Cited by 228
Metadata
- Authors
- Qureshi, F., Pestian, J., Davis, P., & Zaritsky, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-10-08
- Volume
- 339
- Issue
- 15
- Pages
- 1030-1035
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1971073287
- Cited by
- 294
- References
- 8
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Nebulized Ipratropium on the Hospitalization Rates of Children with Asthma. https://app.cochat.ai/papers/10.1056/nejm199810083391503
- The paper
- Qureshi, F., Pestian, J., Davis, P., & Zaritsky, A. (1998). Effect of Nebulized Ipratropium on the Hospitalization Rates of Children with Asthma. New England Journal of Medicine. https://doi.org/10.1056/nejm199810083391503
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.